Literature DB >> 9154329

Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters.

C Pifl1, E Agneter, H Drobny, H Reither, E A Singer.   

Abstract

1. COS-7 cells transfected with the cDNA of the human dopamine transporter (DAT cells) or the human noradrenaline transporter (NAT cells) were loaded with [3H]-dopamine or [3H]-noradrenaline and superfused with buffers of different ionic composition. 2. In DAT cells lowering the Na+ concentration to 0, 5 or 10 mM caused an increase in 3H-efflux. Cocaine (10 microM) or mazindol (0.3 microM) blocked the efflux at low Na+, but not at 0 Na+. Lowering the Cl- concentration to 0, 5 or 10 mM resulted in an increased efflux, which was blocked by cocaine or mazindol. Desipramine (0.1 microM) was without effect in all the conditions tested. 3. In NAT cells, lowering the Na+ concentration to 0, 5 or 10 mM caused an increase in 3H-efflux, which was blocked by cocaine or mazindol. Desipramine produced a partial block, its action being stronger at 5 or 10 mM Na+ than at 0 mM Na+. Efflux induced by 0, 5 or 10 mM Cl- was completely blocked by all three uptake inhibitors. 4. In cross-loading experiments, 5 mM Na(+)- or 0 Cl(-)-induced efflux was much lower from [3H]-noradrenaline-loaded DAT, than NAT cells and was sensitive to mazindol, but not to desipramine. Efflux from [3H]-dopamine-loaded NAT cells elicited by 5 mM Na+ or 0 Cl- was blocked by mazindol, as well as by desipramine. 5. Thus cloned catecholamine transporters display carrier-mediated efflux of amines if challenged by lowering the extracellular Na+ or Cl-, whilst retaining their pharmacological profile. The transporters differ with regard to the ion dependence of the blockade of reverse transport by uptake inhibitors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154329      PMCID: PMC1564686          DOI: 10.1038/sj.bjp.0701137

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.

Authors:  M Syringas; F Janin; B Giros; J Costentin; J J Bonnet
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

Review 2.  The Role of Intracellular Sodium in the Regulation of NMDA-Receptor-Mediated Channel Activity and Toxicity.

Authors:  Xian-Min Yu
Journal:  Mol Neurobiol       Date:  2006-02       Impact factor: 5.590

3.  An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.

Authors:  Rheaclare Fraser; Yongyue Chen; Bipasha Guptaroy; Kathryn D Luderman; Stephanie L Stokes; Asim Beg; Louis J DeFelice; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2014-04-21       Impact factor: 4.436

4.  CNS dopamine transmission mediated by noradrenergic innervation.

Authors:  Caroline C Smith; Robert W Greene
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

5.  Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter.

Authors:  E Percy; D M Kaye; G W Lambert; S Gruskin; M D Esler; X J Du
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 6.  The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.

Authors:  Harald H Sitte; Michael Freissmuth
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

Review 7.  Chloride requirement for monoamine transporters.

Authors:  Louis J De Felice
Journal:  Pflugers Arch       Date:  2016-01-22       Impact factor: 3.657

Review 8.  A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.

Authors:  S D Robertson; H J G Matthies; A Galli
Journal:  Mol Neurobiol       Date:  2009-02-06       Impact factor: 5.590

9.  Classic Studies on the Interaction of Cocaine and the Dopamine Transporter.

Authors:  Vivek Verma
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-12-31       Impact factor: 2.582

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.